The Technical Analyst
Anthera Pharmaceuticals, [ANTH]
Exchange: Other OTC Sector: Healthcare Industry: Biotechnology
Anthera Pharmaceuticals, Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.00% $0.0000
/ 14 mar 2024 @ 10:46
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 0.0062 mill |
| EPS: | -0.0100 |
| P/E: | 0 |
| Earnings Date: | May 09, 2024 |
| SharesOutstanding: | 6 178.00 mill |
| Avg Daily Volume: | 0 mill |
| RATING 2024-01-16 |
|---|
| C+ |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Strong Sell | |
| DE: | Neutral | |
| P/E: | Neutral | |
| Price To Book: | Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/16 | 1/17 | 2/17 | 3/17 | 4/17 | 1/18 | |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Gr.Profit | n/a | n/a | n/a | n/a | n/a | n/a |
| Ebit | ||||||
| Asset | ||||||
| Debt | n/a | n/a | n/a | n/a | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 0 | sector: PE 0 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| N/A |
| Company: PE 0 | industry: PE 0 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.0001 - 0.0001 ( +/- 0.00%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2018-01-05 | Thompson John Craig | Buy | 1 847 074 | Stock Option (right to buy) |
| 2018-01-05 | Shanahan William R Jr | Buy | 567 876 | Stock Option (right to buy) |
| 2018-01-05 | Truex Paul F | Buy | 84 705 | Stock Option (right to buy) |
| 2018-01-05 | Thompson David E. | Buy | 84 705 | Stock Option (right to buy) |
| 2018-01-05 | Sager Philip | Buy | 84 705 | Stock Option (right to buy) |
| INSIDER POWER |
|---|
| 0.00 |
| Last 96 transactions |
| Buy: 6 407 499 | Sell: 1 702 569 |
Forecast: